Daily Visitors
Last scanned
Domain Age
Global Rank
Updated:
Rebif® (interferon beta-1a) Relapsing Multiple Sclerosis (RMS) Treatment
Rebif® (interferon beta-1a) is a treatment for your relapsing multiple sclerosis (RMS) that delivers proven efficacy and a well-established safety profile.
This website is hosted with Akamai Technologies, Inc., which reserves the following IP addresses for rebif.com: 23.13.155.136. Moreover, DNS used with this website include ns1.brandshelter.com, ns2.brandshelter.de, ns3.brandshelter.info, ns4.brandshelter.net, ns5.brandshelter.us. Subnet identifier ranges from 104.64.0.0 to 104.127.255.255. Classless Inter-Domain Routing (CIDR) is 104.64.0.0/10. ARIN net type is Direct Allocation.
Daily Visitors
Last scanned
Domain Age
Global Rank
ns1.brandshelter.com
ns2.brandshelter.de
ns3.brandshelter.info
ns4.brandshelter.net
ns5.brandshelter.us
{{value}}
2001-06-11
2024-06-11
REDACTED FOR PRIVACY
KEY-SYSTEMS GMBH
info@domain-contact.org
{{value}}
The registrar of rebif.com is KEY-SYSTEMS GMBH and the name expires on 2024-06-11. According to open source data, you can reach the owner at info@domain-contact.org but please make sure you have a good reason for unsolicited messages. Their country of residence is Ukraine.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A